Normally, if an overweight person loses a substantial amount of weight, we expect to see improvements in their aerobic fitness (relative to body mass) and cardiovascular health
One of the most effective is semaglutide , a drug designed to act like GLP-1 but last much longer in the body than the hormone itself
This article was produced under Drug Discovery News AI Editorial Guidelines .
Most of these medications are designed to mimic GLP-1 alone
The most successful treatments currently available include glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), exemplified by semaglutide (approved in 2017, $19.9 billion sales in 2023) 3 and tirzepatide (approved in 2022, $5.3 billion sales in 2023) 4
The results demonstrated that Second Nature was more than twice as effective at supporting weight loss after 12 months than the four other providers